文献速递心脑血管急症重症综合管理与镇静镇痛

2021年欧洲复苏委员会/欧洲重症医学会心脏骤停后神经预后不良预测算法——入组标准能否放宽?

2021 European Resuscitation Council/European Society of Intensive Care Medicine Algorithm for Prognostication of Poor Neurological Outcome After Cardiac Arrest-Can Entry Criteria Be Broadened?
PubMed 文献 · Crit Care Med · 2023-12-07
一句话结论2021年ERC/ESICM神经预后算法在心脏骤停后72小时预测不良神经结局假阳性率为0%,放宽入组标准纳入所有无意识患者(GCS-M 1-5)不影响假阳性率。

这项回顾性多中心观察研究纳入瑞典Skane四家ICU的794例心脏骤停后目标温度36°C管理的患者,评估2021年ERC/ESICM神经预后算法的原始入组标准(GCS-M 1-3)与放宽标准(包括持续镇静患者及GCS-M 4-5)的预测性能。原始标准识别163例中115例不良结局,假阳性率0%(95%CI 0-79.4%),敏感度71.0%(95%CI 63.6-77.4%);纳入持续镇静患者额外识别13例不良结局,假阳性率0%(95%CI 0-65.8%),敏感度69.6%(95%CI 62.6-75.8%);纳入所有无意识患者(GCS-M 1-5)额外识别1例,假阳性率0%(95%CI 0-22.8),敏感度62.9%(95%CI 56.1-69.2%)。结论认为该算法预测不良神经结局假阳性率为0%,放宽入组标准可额外识别少量不良结局患者而不影响假阳性率,但结果受高比例撤除生命支持治疗和真阴性预测患者少限制。

要点

  • 2021年ERC/ESICM算法原始入组标准(GCS-M 1-3)在心脏骤停后72小时预测不良神经结局:假阳性率0%(95%CI 0-79.4%),敏感度71.0%(95%CI 63.6-77.4%)。
  • 纳入持续镇静患者额外识别13例不良结局,假阳性率0%(95%CI 0-65.8%),敏感度69.6%(95%CI 62.6-75.8%)。
  • 纳入所有无意识患者(GCS-M 1-5,不论是否镇静)仅额外识别1例不良结局,假阳性率0%(95%CI 0-22.8),敏感度62.9%(95%CI 56.1-69.2%)。
  • 真阴性预测患者(结局良好且不符合指南不良结局标准)极少,导致假阳性率95%CI极宽。
  • 研究结论受高比例撤除生命支持治疗(330/495例死亡发生于撤除决策后)和真阴性预测患者少限制。

适用人群与场景

  • 2014-2018年在瑞典Skane四家ICU接受目标温度36°C管理的心脏骤停后患者,共794例。
  • 中位年龄69.5岁(四分位距60.6-77.0岁),241例(30.4%)为女性,550例(69.3%)为院外心脏骤停,314例(41.3%)为可除颤心律。
  • 心脏骤停后72小时仍无意识者218例。

诊断标准与关键阈值

  • 2021年ERC/ESICM算法原始入组标准:GCS-M评分1-3分。
  • 放宽标准一:纳入持续镇静患者(GCS-M 1-3分且镇静中)。
  • 放宽标准二:纳入所有无意识患者,GCS-M评分1-5分,不论是否镇静。

研究设计与关键结果

  • 研究类型:回顾性多中心观察研究,四家ICU(瑞典Skane),纳入794例心脏骤停后目标温度36°C管理患者,2014-2018年,神经结局于2-6个月后按脑功能分类(CPC)量表评估。
  • 随访时495例死亡,其中330例死于撤除生命支持治疗决策后。
  • 原始入组标准(GCS-M 1-3)符合者163例,识别115例不良结局,假阳性率0%(95%CI 0-79.4%),敏感度71.0%(95%CI 63.6-77.4%)。
  • 纳入持续镇静患者额外识别13例不良结局,假阳性率0%(95%CI 0-65.8%),敏感度69.6%(95%CI 62.6-75.8%)。
  • 纳入所有无意识患者(GCS-M 1-5)额外识别1例不良结局,假阳性率0%(95%CI 0-22.8),敏感度62.9%(95%CI 56.1-69.2%)。
  • 真阴性预测患者(结局良好且不符合指南不良结局标准)极少,导致假阳性率95%CI极宽。

证据类型、等级与局限

  • 证据类型:回顾性多中心观察研究。
  • 局限:高比例撤除生命支持治疗;真阴性预测患者少导致假阳性率95%CI宽。

对床旁实践的改变

  • 2021年ERC/ESICM算法在心脏骤停后72小时以GCS-M 1-3为标准预测不良神经结局假阳性率0%,可依据该算法进行神经预后评估。
  • 将入组标准放宽至所有无意识患者(GCS-M 1-5,不论是否镇静)可额外识别少量不良结局患者,且不影响假阳性率,但敏感度降至62.9%(95%CI 56.1-69.2%)。
  • 结果解释需考虑高比例撤除生命支持治疗和真阴性预测患者少带来的局限。

指南或共识出处

  • 2021年欧洲复苏委员会/欧洲重症医学会(ERC/ESICM)心脏骤停后神经预后算法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To explore broadened entry criteria of the 2021 European Resuscitation Council/European Society of Intensive Care Medicine (ERC/ESICM) algorithm for neuroprognostication including patients with ongoing sedation and Glasgow Coma Scale-Motor score (GCS-M) scores 4-5.

DESIGN: Retrospective multicenter observational study.

SETTING: Four ICUs, Skane, Sweden.

PATIENTS: Postcardiac arrest patients managed at targeted temperature 36°C, 2014-2018. Neurologic outcome was assessed after 2-6 months according to the Cerebral Performance Category scale.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: In 794 included patients, median age was 69.5 years (interquartile range, 60.6-77.0 yr), 241 (30.4%) were female, 550 (69.3%) had an out-of-hospital cardiac arrest, and 314 (41.3%) had a shockable rhythm. Four hundred ninety-five patients were dead at follow-up, 330 of 495 died after a decision on withdrawal of life-sustaining therapies. At 72 hours after cardiac arrest 218 patients remained unconscious. The entry criteria of the original algorithm (GCS-M 1-3) was fulfilled by 163 patients and 115 patients with poor outcome were identified, with false positive rate (FPR) of 0% (95% CI, 0-79.4%) and sensitivity of 71.0% (95% CI, 63.6-77.4%). Inclusion of patients with ongoing sedation identified another 13 patients with poor outcome, generating FPR of 0% (95% CI, 0-65.8%) and sensitivity of 69.6% (95% CI, 62.6-75.8%). Inclusion of all unconscious patients (GCS-M 1-5), regardless of sedation, identified one additional patient, generating FPR of 0% (95% CI, 0-22.8) and sensitivity of 62.9% (95% CI, 56.1-69.2). The few patients with true negative prediction (patients with good outcome not fulfilling guideline criteria of a poor outcome) generated wide 95% CI for FPR.

CONCLUSION: The 2021 ERC/ESICM algorithm for neuroprognostication predicted poor neurologic outcome with a FPR of 0%. Broadening inclusion criteria to include all unconscious patients regardless of ongoing sedation identified an additional small number of patients with poor outcome but did not affect the FPR. Results are limited by high rate of withdrawal of life-sustaining therapies and few patients with true negative prediction.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Arctaedius I, Levin H, Larsson M, et al. 2021 European Resuscitation Council/European Society of Intensive Care Medicine Algorithm for Prognostication of Poor Neurological Outcome After Cardiac Arrest-Can Entry Criteria Be Broadened? Crit Care Med. 2023. PMID: 38059722. doi:10.1097/CCM.0000000000006113

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。